Hs-CRP is a strong predictor of adverse cardiovascular events in patients with chest pain
Betül Toprak(Universität Hamburg), J T Neumann(University Cancer Center Hamburg), Lea Scharlemann(Universität Hamburg), J Lehmacher(University Cancer Center Hamburg), N Thiessen(University Cancer Center Hamburg), B Voelschow(University Cancer Center Hamburg), A Schock(University Cancer Center Hamburg), N A Soerensen(University Cancer Center Hamburg), C Kellner(University Cancer Center Hamburg), T Zeller(Institute for Integrative and Experimental Genomics), P M Haller(University Cancer Center Hamburg), Raphael Twerenbold(German Centre for Cardiovascular Research)
Cited by 1
Related Papers
Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme
|European Heart Journal|2021|176
Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure
|Journal of the American College of Cardiology|2017|90
Markers of Plaque Instability in the Early Diagnosis and Risk Stratification of Acute Myocardial Infarction
|Clinical Chemistry|2011|69
Personalized diagnosis in suspected myocardial infarction
|Clinical Research in Cardiology|2023|37